Extracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential
Dellar ER. et al, (2025), Molecular Neurodegeneration, 20
Progression and life expectancy in primary lateral sclerosis
Lester DG. et al, (2025), Journal of Neurology, Neurosurgery & Psychiatry
Service evaluation of having an additional CT scan for motor neurone disease patients undergoing a gastrostomy.
Newman J. et al, (2025), Br J Nurs, 34, S4 - S8
Asymmetry in amyotrophic lateral sclerosis: clinical, neuroimaging and histological observations.
Yoganathan K. et al, (2025), Brain
Drug repurposing in amyotrophic lateral sclerosis (ALS)
Carroll E. et al, (2025), Expert Opinion on Drug Discovery, 1 - 18
Elevated Cerebrospinal Fluid Ubiquitin Carboxyl‐Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion Carriers
Dellar ER. et al, (2024), Annals of Neurology
The Basis of Cognitive and Behavioral Dysfunction in Amyotrophic Lateral Sclerosis.
Bampton A. et al, (2024), Brain Behav, 14
Apolipoproteins, lipids, lipid-lowering drugs and risk of amyotrophic lateral sclerosis and frontotemporal dementia: a meta-analysis and Mendelian randomisation study
Chalitsios CV. et al, (2024), Journal of Neurology
Personalised penetrance estimation forC9orf72-related amyotrophic lateral sclerosis and frontotemporal dementia
Douglas AGL. et al, (2024), BMJ Neurology Open, 6, e000792 - e000792
Publisher Correction: The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology.
Benatar M. et al, (2024), Nat Rev Neurol, 20
The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology.
Benatar M. et al, (2024), Nat Rev Neurol, 20, 364 - 376
The cortical neurophysiological signature of amyotrophic lateral sclerosis
Trubshaw M. et al, (2024), Brain Communications
Venous thromboembolism risk in amyotrophic lateral sclerosis: a hospital record-linkage study.
Goldacre R. et al, (2024), J Neurol Neurosurg Psychiatry
Premorbid brain structure influences risk of amyotrophic lateral sclerosis.
Thompson AG. et al, (2023), J Neurol Neurosurg Psychiatry
Data-independent acquisition proteomics of cerebrospinal fluid implicates endoplasmic reticulum and inflammatory mechanisms in amyotrophic lateral sclerosis
Dellar E. et al, (2023), Journal of Neurochemistry
Primary care blood tests show lipid profile changes in pre-symptomatic amyotrophic lateral sclerosis
Thompson AG. et al, (2023), Brain Communications
Advantages of routine next‐generation sequencing over standard genetic testing in the amyotrophic lateral sclerosis clinic
Scaber J. et al, (2023), European Journal of Neurology
Limited value of serum neurofilament light chain in diagnosing amyotrophic lateral sclerosis
Davies JC. et al, (2023), Brain Communications, 5
Profiling non-coding RNA expression in cerebrospinal fluid of amyotrophic lateral sclerosis patients.
Joilin G. et al, (2022), Ann Med, 54, 3069 - 3078
Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysis
Gao J. et al, (2022), Journal of Neurology, 269, 5395 - 5404